영백염전

비상장계속사업자

youngbeck saltfarm co.,ltd

김영관

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

영백염전

Business Reg. No. 4108619656 · CEO 김영관

I.Investment Overview

Target영백염전 (4108619656)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명영백염전
영문명youngbeck saltfarm co.,ltd
대표자김영관
사업자등록번호4108619656
법인등록번호2058110009080
설립일2008.05.29

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW6.1202110.1202211.9202310.8202423.52025
영업이익100M KRW2.720217.320228.620237.5202421.82025
순이익100M KRW2.920211.720223.320231.12024-41.52025
Item20252024202320222021
자산총계297.2억원270.9억원254.3억원205.9억원213.1억원
부채총계327.8억원265억원249.5억원204.4억원213.3억원
자본총계-30.5억원5.9억원4.8억원1.5억원-2,147만원
매출액23.5억원10.8억원11.9억원10.1억원6.1억원
영업이익21.8억원7.5억원8.6억원7.3억원2.7억원
순이익-41.5억원1.1억원3.3억원1.7억원2.9억원

VI.Financial Ratios

FY2025 basis

92.83%

영업이익률

-176.29%

순이익률

-13.96%

ROA

ROE

부채비율

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

영백염전 투심보고서 | Alpha Lenz